Skip to main content

UBS Group AG

Position in LSTA — Lisata Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in LSTA

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$9,563
+$7,943 QoQ
Shares Held
1,909
+119.2% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2022
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LSTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. LSTA ranks #463 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LSTA

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $9,563 1,909
2025-12-31 $1,620 871
2025-06-30 $20,499 7,069
2025-03-31 $2 1
2024-12-31 $2 1
2024-09-30 $375 125
2024-06-30 $12,869 3,709
2024-03-31 $3 1
2023-12-31 $643 236
2023-09-30 $305 143
2023-06-30 $3 1
2023-03-31 $3 1
2022-12-31 $14,918 5,897
2022-09-30 $21,704 4,688